Los Angeles, CA, United States of America

Ke Cheng

This inventor holds 4 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Cedars-Sinai Medical Center. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ke Cheng. Retrieved from https://idiyas.com/inventor/ke-cheng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ke Cheng

Introduction

Ke Cheng is a prominent inventor based in Los Angeles, CA. He has made significant strides in the field of tissue regeneration, holding a total of 4 patents. His work focuses on utilizing exosomes and micro-ribonucleic acids to repair and regenerate damaged tissues.

Latest Patents

One of Ke Cheng's latest patents involves methods for repairing and regenerating damaged or diseased tissue. This patent describes the administration of compositions comprising exosomes to the affected areas. The exosomes contain microRNA that can alter gene or protein expression, leading to improved cell viability and function. This innovative approach has the potential to revolutionize treatments for various tissue injuries.

Career Highlights

Ke Cheng is affiliated with Cedars-Sinai Medical Center, where he conducts his research and development. His work has garnered attention for its potential applications in regenerative medicine. His contributions to the field are recognized for their scientific rigor and practical implications.

Collaborations

Some of his notable coworkers include Ahmed Ibrahim and Eduardo Marbán. Their collaborative efforts enhance the research environment and contribute to the advancement of innovative solutions in tissue regeneration.

Conclusion

Ke Cheng's work exemplifies the intersection of innovation and medical science. His patents and research are paving the way for new treatments that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…